PMC Members Luncheon
"Advancing Towards the Era of Personalized Medicine: FDA’s Pharmacogenomics Initiative"
Lunch and Conversation with:
Janet Woodcock, M.D.
Acting Deputy Commissioner for Operations, U.S. Food and Drug Administration
| PMC MEMBERS ONLY |
According to Janet Woodcock, “FDA’s efforts [in pharmacogenomics] will bring us one step closer to ‘personalizing’ medical treatment. This new technology will allow medicines to be uniquely crafted to maximize their therapeutic benefits and minimize their potential risks for each patient.”
Please join us for a discussion about how the FDA will facilitate this vision of the future.
 |
|
Date: |
|